WO2002004497A3 - Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae - Google Patents

Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae Download PDF

Info

Publication number
WO2002004497A3
WO2002004497A3 PCT/US2001/021626 US0121626W WO0204497A3 WO 2002004497 A3 WO2002004497 A3 WO 2002004497A3 US 0121626 W US0121626 W US 0121626W WO 0204497 A3 WO0204497 A3 WO 0204497A3
Authority
WO
WIPO (PCT)
Prior art keywords
streptococcus pneumoniae
antigenic peptides
against streptococcus
multiple antigenic
peptides
Prior art date
Application number
PCT/US2001/021626
Other languages
English (en)
Other versions
WO2002004497A2 (fr
Inventor
Edwin W Ades
Scott E Johnson
Danny L Jue
Jacquelyn S Sampson
George M Carlone
Original Assignee
Us Gov Health & Human Serv
Edwin W Ades
Scott E Johnson
Danny L Jue
Jacquelyn S Sampson
George M Carlone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/613,092 external-priority patent/US6903184B1/en
Application filed by Us Gov Health & Human Serv, Edwin W Ades, Scott E Johnson, Danny L Jue, Jacquelyn S Sampson, George M Carlone filed Critical Us Gov Health & Human Serv
Priority to CA2416224A priority Critical patent/CA2416224C/fr
Priority to AU7193501A priority patent/AU7193501A/xx
Priority to AU2001271935A priority patent/AU2001271935B2/en
Priority to JP2002509360A priority patent/JP4703091B2/ja
Priority to EP01950993A priority patent/EP1301530A2/fr
Publication of WO2002004497A2 publication Critical patent/WO2002004497A2/fr
Publication of WO2002004497A3 publication Critical patent/WO2002004497A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des peptides à antigènes multiples (MAP) qui confèrent une protection contre l'infection par S. pneumoniae. Ces peptides à antigènes multiples comprennent des peptides qui se lient de manière immunospécifique aux anticorps monoclonaux. La présente invention concerne également des vaccins renfermant ces mêmes peptides immunogènes ainsi que des procédés qui permettent de conférer une immunité de protection contre l'infection par Streptococcus pneumoniae au moyen de l'administration d'une composition thérapeutique comprenant les MAP selon l'invention.
PCT/US2001/021626 2000-07-10 2001-07-10 Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae WO2002004497A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2416224A CA2416224C (fr) 2000-07-10 2001-07-10 Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae
AU7193501A AU7193501A (en) 2000-07-10 2001-07-10 Multiple antigenic peptides immunogenic against streptococcus pneumoniae
AU2001271935A AU2001271935B2 (en) 2000-07-10 2001-07-10 Multiple antigenic peptides immunogenic against streptococcus pneumoniae
JP2002509360A JP4703091B2 (ja) 2000-07-10 2001-07-10 Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅに対して免疫原性である複数抗原性ペプチド
EP01950993A EP1301530A2 (fr) 2000-07-10 2001-07-10 Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/613,092 US6903184B1 (en) 1998-03-02 2000-07-10 Multiple antigenic peptides immunogenic against Streptococcus pneumonia
US09/613,092 2000-07-10

Publications (2)

Publication Number Publication Date
WO2002004497A2 WO2002004497A2 (fr) 2002-01-17
WO2002004497A3 true WO2002004497A3 (fr) 2002-08-01

Family

ID=24455832

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021626 WO2002004497A2 (fr) 2000-07-10 2001-07-10 Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae

Country Status (5)

Country Link
EP (1) EP1301530A2 (fr)
JP (2) JP4703091B2 (fr)
AU (2) AU7193501A (fr)
CA (1) CA2416224C (fr)
WO (1) WO2002004497A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
AU2005332058B2 (en) * 2005-05-19 2011-12-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
JP6739702B2 (ja) 2014-06-11 2020-08-12 国立研究開発法人理化学研究所 多重同種抗原ペプチド
JP2018070571A (ja) * 2016-11-04 2018-05-10 国立研究開発法人理化学研究所 免疫誘導剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
WO1999040200A1 (fr) * 1998-02-03 1999-08-12 Center For Disease Control And Prevention PROTEINE PsaA RECOMBINEE LIPIDEE, METHODES DE PREPARATION ET D'UTILISATION
WO1999045121A1 (fr) * 1998-03-02 1999-09-10 The Government Of The United States Of America, Represented By The Secretary Of The Department Health And Human Services PEPTIDES EPITOPES IMMUNOGENES CONTRE L'INFECTION PAR $i(STREPTOCOCCUS PNEUMONIAE)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
JP2002533115A (ja) * 1998-12-31 2002-10-08 ザ ジェネラル ホスピタル コーポレーション Ｐｔｈ機能的ドメイン結合体ペプチド、それらの誘導体、および新規係留リガンド−レセプター分子

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
WO1999040200A1 (fr) * 1998-02-03 1999-08-12 Center For Disease Control And Prevention PROTEINE PsaA RECOMBINEE LIPIDEE, METHODES DE PREPARATION ET D'UTILISATION
WO1999045121A1 (fr) * 1998-03-02 1999-09-10 The Government Of The United States Of America, Represented By The Secretary Of The Department Health And Human Services PEPTIDES EPITOPES IMMUNOGENES CONTRE L'INFECTION PAR $i(STREPTOCOCCUS PNEUMONIAE)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KATHERINE E. MORRISON ET AL.: "Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 38, no. 1, January 2000 (2000-01-01), pages 434 - 437, XP002192347 *
N. SRIVASTAVA ET AL.: "Selection of an immunogenic and protective epitope of the psaA protein of Streptococcus pneumoniae using a phage display library", HYBRIDOMA, vol. 19, no. 1, February 2000 (2000-02-01), pages 23 - 31, XP001064205 *
SAMPSON ET AL: "Limited Diversity of Streptococcus pneumoniae psaA among Pneumococcal Vaccine Serotypes", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 65, no. 5, May 1997 (1997-05-01), pages 1967 - 1971, XP002108304, ISSN: 0019-9567 *

Also Published As

Publication number Publication date
EP1301530A2 (fr) 2003-04-16
WO2002004497A2 (fr) 2002-01-17
CA2416224A1 (fr) 2002-01-17
JP4703091B2 (ja) 2011-06-15
JP2004502782A (ja) 2004-01-29
JP2011057691A (ja) 2011-03-24
AU2001271935B2 (en) 2006-09-14
CA2416224C (fr) 2015-08-25
AU7193501A (en) 2002-01-21

Similar Documents

Publication Publication Date Title
WO2000076540A3 (fr) Proteines et vaccins de streptococcus pneumoniae
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
WO2000062800A3 (fr) Vaccins
WO2006041933A3 (fr) Vaccins ameliores
WO2006032472A3 (fr) Composition immunogene
WO2003011223A3 (fr) Composes immunomodulants et methodes d'utilisation
AU2001295673A1 (en) Vaccine composition
WO2003065973A8 (fr) Compositions de vaccins multivalents a base de streptocoques et procedes d'utilisation
HUP9903770A2 (hu) Eljárások és készítmények többepitópos antigének konformációjának megváltoztatására immunválasz kiváltása céljából
WO2001081380A3 (fr) Proteine pneumococcique immunogenique et ses compositions de vaccins
WO2004043376A3 (fr) Compositions et methodes de traitement ou de prevention d'une infection a pneumocoques
HUP0203972A2 (hu) Antigént és glikolipidet tartalmazó készítmény szublingvális úton történő alkalmazásra
MY125000A (en) Novel compositions
WO2001079259A8 (fr) Complexation d'antigenes proteiques et de proteines de stress par sequence javelot
WO2005028496A3 (fr) Vaccin pour le traitement et la prevention de l'infection provoquee par le virus de l'herpes simplex
WO2002034773A3 (fr) Genes streptococciques
WO2005028618A3 (fr) Compositions immunogenes pour streptococcus agalactiae
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
WO1999052548A3 (fr) Vaccins conjugues pour la prevention contre les caries dentaires
WO2001096370A3 (fr) Antigenes de cryptosporidium parvum, anticorps diriges contres lesdits antigenes et compositions therapeutiques associees
WO2002034287A3 (fr) Nouvelles formulations de vaccin therapeutique
WO2003083083A3 (fr) Procedes d'utilisation d'un ligand flt3 dans des protocoles d'immunisation
WO2002004497A3 (fr) Peptides a antigenes multiples assurant l'immunite contre streptococcus pneumoniae
WO2005007804A3 (fr) Vaccin conjugue contre l'anthrax et anticorps diriges contre des bacilles et des toxines de l'anthrax
WO2004022092A3 (fr) Adjuvants

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001271935

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001950993

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 509360

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2416224

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2001950993

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001950993

Country of ref document: EP